At a glance
ClinicalIndex Comparison Record- ✓Spontaneous intermenstrual periods of 45 days or longer, or 8 or fewer periods per year
- ✓Elevated testosterone levels
- ✓General good health
- ✓Off current medications that may confound response to study medications
- ✕Pregnancy
- ✕Lactose intolerance
- ✕Medical contraindications to study drugs
- ✕Elevated prolactin, 17-hydroxyprogesterone, or follicle-stimulating hormone on blood tests
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect of Combination Therapy With Lifestyle Intervention and Metformin in Females With Polycystic Ovary Syndrome
In Brief
A Phase 2 clinical trial evaluating Metformin, Placebo, and 1 other intervention for Polycystic Ovary Syndrome. Completed, enrolled 114 participants across 1 site.
Detailed Summary
The purpose of this study is to determine if the combination therapy of lifestyle intervention and use of Metformin together will improve ovulation induction and hyperandrogenemia in women with polycystic ovary syndrome, by gathering data from adult and adolescent females.
Study Details
Timeline
Interventions
Medication was initiated in a step-up fashion every five days, from one tablet per day to four (500 mg per tablet).
Placebo
A combined intervention of diet and exercise was employed with the goal of achieving an average weight loss of at least 7% of initial body weight over six months with a prescription of 150 min/week of exercise combined with a low-calorie diet.